Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Presented on .

This session of Grand Rounds explored High-Impact HIV Prevention in the United States. Because HIV incidence is stable and effective treatment exists to prevent illness and death, a growing number of persons—over 1.1 million–are living with HIV. The growing number with the potential to transmit HIV presents a challenge for prevention. At the same time, recent scientific breakthroughs in treatment, prevention, and monitoring disease have equipped us with an unprecedented number of effective tools to prevent infection. High Impact HIV Prevention seeks the most effective distribution of limited resources, considering the effectiveness and cost of prevention interventions and the feasibility of full-scale implementation.

New directions in monitoring the burden of HIV and resource allocation modeling of HIV prevention interventions were presented as well as the White House’s ongoing implementation of the National HIV/AIDS Strategy to improve HIV prevention and care.

Presented By

Jonathan Mermin, MD, MPH
Director, Division of HIV/AIDS Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Irene Hall, PhD, MPH, FACE
Chief, HIV Incidence and Case Surveillance Branch
Division of HIV/AIDS Prevention

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
CDR Stephanie Sansom, PhD, MPP, MPH
Lead, Prevention Economics Team
Quantitative Sciences and Data Management Branch
Division of HIV/AIDS Prevention

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC
Grant Colfax, MD
Director
Office of National AIDS Policy

Facilitated By

Tanja Popovic, MD, PhD
Scientific Director
John Iskander, MD, MPH
Deputy Scientific Director
Susan Laird, MSN, RN
Communications Director

Enjoyed this Presentation?

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!Sign Up

Sign Up

Get notified about the latest updates from Public Health Grand Rounds right in your inbox by setting up an alert today!

You May Also Like

PrEP HIV

May 2014, HIV/STD/TB
HIV and pills

An estimated 50,000 individuals become infected with the human immunodeficiency virus (HIV) in the United States annually. A new prevention strategy, Pre-exposure Prophylaxis (PrEP), is intended to help high-risk populations reduce their risk of HIV infection. Learn about this promising tool.

TB and HIV

March 2011, HIV/STD/TB
Three men, smiling

Tuberculosis (TB) still remains a serious threat, especially for those infected with HIV. HIV is the single most powerful risk factor for TB disease and one of the leading causes of death among people infected with HIV. Learn about TB and HIV and hear what is needed to prevent deaths from this lethal combination.

  • Page last reviewed: February 28, 2018
  • Page last updated: February 28, 2018
  • Content source:
    • Office of the Associate Director for Science
    • Page maintained by: Office of the Associate Director for Communication
TOP